Your browser doesn't support javascript.
loading
Comprehensive Assessment of the Clinical Risk Factors of Postoperative Adverse Events and Survival in Patients With Non-small-cell Lung Cancer.
Chang, Bee-Song; Peng, Tai-Chu; Lue, Kun-Han; Wu, Yi-Feng; Huang, Chun-Hou.
Afiliação
  • Chang BS; Department of Cardiothoracic Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, R.O.C.
  • Peng TC; School of Medicine, College of Medicine, Tzu Chi University, Hualien, Taiwan, R.O.C.
  • Lue KH; Department of Nursing, Tzu Chi University, Hualien, Taiwan, R.O.C.
  • Wu YF; Department of Medical Imaging and Radiological Sciences, Tzu Chi University of Science and Technology, Hualien, Taiwan, R.O.C.
  • Huang CH; School of Medicine, College of Medicine, Tzu Chi University, Hualien, Taiwan, R.O.C.
In Vivo ; 37(3): 1358-1364, 2023.
Article em En | MEDLINE | ID: mdl-37103097
BACKGROUND/AIM: Postoperative adverse events are associated with poor clinical outcomes and survival in patients with non-small-cell lung cancer (NSCLC) treated with curative operation. However, comprehensive evaluation of the clinical characteristics associated with postoperative adverse events and survival outcomes is lacking. PATIENTS AND METHODS: A retrospective study that evaluated patients with NSCLC who underwent curative surgery between 2008 and 2019 was conducted in a medical center. The baseline characteristics, five-item modified frailty index, sarcopenia, inflammatory biomarkers, surgical approach, postoperative adverse events, and survival were statistically analyzed. RESULTS: Patients with a history of smoking and preoperative sarcopenia were at a higher risk of developing postoperative pulmonary complications. Smoking, frailty, and traditional open thoracotomy (OT) were associated with infections, and sarcopenia was identified as a risk factor for major complications. Advanced tumor stage, high neutrophil-to-lymphocyte ratio, OT, major complications, and infections were identified as risk factors for overall and disease-free survival. CONCLUSION: Pre-treatment sarcopenia was found to be a predictor of major complications. Infections and major complications were associated with survival outcomes in patients with NSCLC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Sarcopenia / Fragilidade / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Sarcopenia / Fragilidade / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article